FORBES-TATE

Lobbying for ANTIMICROBIAL INNOVATION ALLIANCE · Development of antimicrobial resistance policy to assist life sciences industry.

Filing 4th Quarter - Termination

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · posted Jan 19, 2026

Lobbying activity 1

Health Issues

Issues related to the development of critical need antimicrobial biopharmaceuticals.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.